Cardiovascular morbidity in long-term survivors of metastatic testicular cancer.

  title={Cardiovascular morbidity in long-term survivors of metastatic testicular cancer.},
  author={Martin T Meinardi and Jourik A. Gietema and Winette T A van der Graaf and D. J. Van Veldhuisen and M A Runne and Wim J. Sluiter and Elisabeth G. E. de Vries and Pax H. B. Willemse and Nanno H. Mulder and Maarten P. van den Berg and Heimen Schraffordt Koops and Dirk Th Sleijfer},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  volume={18 8},
PURPOSE To determine whether long-term survivors of metastatic testicular cancer have an increased risk of cardiovascular morbidity more than 10 years after chemotherapy. PATIENTS AND METHODS Eighty-seven patients treated with cisplatin-containing chemotherapy before 1987 who were in remission for at least 10 years and whose ages were </= 50 years at the time of analysis were evaluated for the occurrence of cardiovascular events. Sixty-two of 87 patients were additionally evaluated for… CONTINUE READING